ArticleFrontiers in oncology2024

Independent association between prostate-specific antigen nadir and PSA progression-free survival in first-line abiraterone acetate treatment in castration-resistant prostate cancer patients: a pilot study.

Hong Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.